AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36266762 — intervention group
Group type: EXPERIMENTAL
Intervention: risankizumab 360 mg SC
Number of subjects: 1881
Study 36266762 — intervention group
Group type: COMPARATOR
Intervention: placebo IV
Number of subjects: 1881
Study 32420786 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin (500-mg capsules twice daily)
Number of subjects: 39
Study 32420786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 32420786 — intervention group
Group type: COMPARATOR
Intervention: Curcumin vs Placebo
Number of subjects: 39
Study 33819703 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine Learning-based radiomic model using MRI sequences (T1-weighted, T2-weighted, T2-FLAIR, postcontrast T1-weighted, and ADC maps)
Number of subjects: 109
Study 33819703 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine Learning-based radiomic model using MRI sequences
Number of subjects: 109
Study 34219221 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 115
Study 34219221 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 115
Study 34401946 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical motor (machine-driven group)
Number of subjects: 40
Study 34401946 — intervention group
Group type: COMPARATOR
Intervention: Torque wrench (manual group)
Number of subjects: 40
Study 32927324 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS program
Number of subjects: 171
Study 32927324 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 171
Study 32872411 — intervention group
Group type: EXPERIMENTAL
Intervention: SNAP‐Ed
Number of subjects: 328
Study 36078595 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial Incentives for Quitting Smoking (FIMs)
Number of subjects: 0
Study 36078595 — intervention group
Group type: COMPARATOR
Intervention: Smoking Cessation Campaigns (CAMs)
Number of subjects: 0
Study 33512695 — intervention group
Group type: EXPERIMENTAL
Intervention: Ottawa Emergency Department Shift Observation Tool (O-EDShOT)
Number of subjects: 24
Study 33512695 — intervention group
Group type: COMPARATOR
Intervention: daily encounter cards
Number of subjects: 24
Study 32702315 — intervention group
Group type: EXPERIMENTAL
Intervention: AR101 oral immunotherapy
Number of subjects: 175
Study 32702315 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study 35674042 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment
Number of subjects: 3313
Study 35750106 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep-learning signature
Number of subjects: 302
Study 35750106 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk group
Number of subjects: 302
Study 35750106 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid radiomics nomogram
Number of subjects: 302
Study 34134903 — intervention group
Group type: EXPERIMENTAL
Intervention: Vibrotactile Feedback (VF) using VocaLog2 device
Number of subjects: 8
Study 34134903 — intervention group
Group type: COMPARATOR
Intervention: Lee Silverman Voice Treatment (LSVT LOUD®) combined with VF
Number of subjects: 8
Study 33880813 — intervention group
Group type: EXPERIMENTAL
Intervention: Purslane extract (300 mg/day)
Number of subjects: 74
Study 33880813 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 32869230 — intervention group
Group type: EXPERIMENTAL
Intervention: EMS (mechanical simulator practice)
Number of subjects: 12
Study 32869230 — intervention group
Group type: COMPARATOR
Intervention: non-EMS (control)
Number of subjects: 12
Study 34039580 — intervention group
Group type: EXPERIMENTAL
Intervention: Early elective ascending aortic surgery
Number of subjects: 618
Study 34039580 — intervention group
Group type: COMPARATOR
Intervention: Medical surveillance
Number of subjects: 618
Study 32562683 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide (1.5 mg, subcutaneous injections once a week)
Number of subjects: 9901
Study 32562683 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equal volume of matching placebo, subcutaneous injections once a week)
Number of subjects: 9901
Study 36396438 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryoballoon Pulmonary Vein Isolation (PVI)
Number of subjects: 113
Study 36396438 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency CTI ablation
Number of subjects: 113
Study 33333295 — intervention group
Group type: EXPERIMENTAL
Intervention: Tralokinumab 300 mg every 2 weeks
Number of subjects: 204
Study 33333295 — intervention group
Group type: EXPERIMENTAL
Intervention: All tralokinumab doses
Number of subjects: 204
Study 33333295 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicornuate uterus group (vaginal delivery)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Unicornuate uterus group (cesarean section)
Number of subjects: 80
Study 32854474 — intervention group
Group type: COMPARATOR
Intervention: Control group (vaginal delivery)
Number of subjects: 80
Study 32854474 — intervention group
Group type: COMPARATOR
Intervention: Control group (cesarean section)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum hemorrhage (vaginal delivery)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum hemorrhage (cesarean section)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Time of first stage of labor
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Time of second stage of labor
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Neonatal birth weight
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: One-minute Apgar score (premature)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-minute Apgar score (premature)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: One-minute Apgar score (full-term)
Number of subjects: 80
Study 32854474 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-minute Apgar score (full-term)
Number of subjects: 80
Study 33947444 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-led surveillance (n = 300)
Number of subjects: 600
Study 33947444 — intervention group
Group type: COMPARATOR
Intervention: Clinician-led surveillance (n = 300)
Number of subjects: 600
Study 36053970 — intervention group
Group type: EXPERIMENTAL
Intervention: edaravone-edaravone (EE)
Number of subjects: 304
Study 36053970 — intervention group
Group type: COMPARATOR
Intervention: edaravone-placebo (EP)
Number of subjects: 304
Study 36053970 — intervention group
Group type: COMPARATOR
Intervention: placebo-edaravone (PE)
Number of subjects: 304
Study 35578315 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management of sedative therapy with dexmedetomidine
Number of subjects: 190
Study 35578315 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 190
Study 34431819 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,064 nm laser alone
Number of subjects: 20
Study 34431819 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,940 nm laser alone
Number of subjects: 20
Study 34431819 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (1,064 nm and 2,940 nm lasers)
Number of subjects: 20
Study 32483870 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT)
Number of subjects: 14
Study 33992255 — intervention group
Group type: EXPERIMENTAL
Intervention: Coplanar arrangement of continuous shortwave diathermy (CSWD)
Number of subjects: 18
Study 33992255 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraplanar arrangement of continuous shortwave diathermy (CSWD)
Number of subjects: 18
Study 33992255 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal arrangement of continuous shortwave diathermy (CSWD)
Number of subjects: 18
Study 33028390 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Nano stemless total shoulder arthroplasty
Number of subjects: 122
Study 33028390 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive stemmed total shoulder arthroplasty
Number of subjects: 122
Study 33028390 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 122
Study 34423832 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg/kg methylprednisolone
Number of subjects: 168
Study 34423832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 168
Study 34347776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster of young patients without comorbidities for community-acquired pneumonia (n = 1,603)
Number of subjects: 6046
Study 34347776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster of young patients without comorbidities for meningitis or encephalitis (n = 149)
Number of subjects: 6046
Study 34347776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster of elderly patients with COPD for bronchial infection (n = 243)
Number of subjects: 6046
Study 34347776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster of elderly patients with comorbidities and organ failures (n = 1,094)
Number of subjects: 6046
Study 34347776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster of patients after surgery with nosocomial infection (n = 623)
Number of subjects: 6046
Study 34347776 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster of young patients with immunosuppressive conditions (n = 338)
Number of subjects: 6046
Study 34936023 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal pelvic floor muscle training (PFMT) during pregnancy for 12 weeks
Number of subjects: 298
Study 34936023 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care during pregnancy
Number of subjects: 298
Study 34682317 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal Isolation Training (PIT)
Number of subjects: 11
Study 34682317 — intervention group
Group type: COMPARATOR
Intervention: Detraining (DT)
Number of subjects: 11
Study 32874098 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor Cycling (IC)
Number of subjects: 18
Study 32874098 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-Country Skiing (XCS)
Number of subjects: 18
Study 32874098 — intervention group
Group type: COMPARATOR
Intervention: Alpine Skiing (AS)
Number of subjects: 18
Study 33544984 — intervention group
Group type: EXPERIMENTAL
Intervention: 37% carbamide peroxide (CP)
Number of subjects: 45
Study 33544984 — intervention group
Group type: COMPARATOR
Intervention: 35% hydrogen peroxide (HP)
Number of subjects: 45
Study 33544984 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CP and HP
Number of subjects: 45
Study 32881359 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromhexine hydrochloride (BRH) tablets, 32 mg t.i.d. for 14 days
Number of subjects: 18
Study 32881359 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatment according to China's Novel Coronavirus Pneumonia Diagnosis and Treatment Plan)
Number of subjects: 18
Study 32032087 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative care (usual trauma care plus additional resources, psychosocial and movement strategies)
Number of subjects: 99
Study 32032087 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative care
Number of subjects: 99
Study 32032087 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 99
Study 35118740 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular acupuncture (AA) treatment for 8 weeks
Number of subjects: 75
Study 35118740 — intervention group
Group type: COMPARATOR
Intervention: Sham auricular point acupuncture (control)
Number of subjects: 75
Study 34360391 — intervention group
Group type: EXPERIMENTAL
Intervention: Social aspects (relationship with neighbours, satisfaction with the neighbourhood)
Number of subjects: 1973
Study 34360391 — intervention group
Group type: EXPERIMENTAL
Intervention: Density of agglomeration (inner city vs rural areas)
Number of subjects: 1973
Study 34360391 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise sensitivity
Number of subjects: 1973
Study 34360391 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential satisfaction
Number of subjects: 1973
Study 32488378 — intervention group
Group type: EXPERIMENTAL
Intervention: Using the Patient Concerns Inventory (PCI)
Number of subjects: 288
Study 32488378 — intervention group
Group type: COMPARATOR
Intervention: Not using the Patient Concerns Inventory (PCI)
Number of subjects: 288
Study 35279258 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP-1002 (1·5 × 10^8 CDCs)
Number of subjects: 26
Study 35279258 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 35986259 — intervention group
Group type: EXPERIMENTAL
Intervention: WELLBASED intervention programme for 12 months
Number of subjects: 875
Study 35986259 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 875
Study 34390762 — intervention group
Group type: EXPERIMENTAL
Intervention: Omarigliptin (once-weekly DPP-4 inhibitor)
Number of subjects: 36
Study 34390762 — intervention group
Group type: COMPARATOR
Intervention: Once-daily DPP-4 inhibitors (control)
Number of subjects: 36
Study 32448677 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual training (40 hours)
Number of subjects: 79
Study 32448677 — intervention group
Group type: EXPERIMENTAL
Intervention: Auditory training (40 hours)
Number of subjects: 79
Study 32448677 — intervention group
Group type: COMPARATOR
Intervention: Both training groups
Number of subjects: 79
Study 35831736 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous extract of seed of broccoli (AESB)
Number of subjects: 110
Study 35831736 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 33837380 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (EX)
Number of subjects: 120
Study 33837380 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 120
Study 33950795 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed models of the canine heart (3DM)
Number of subjects: 31
Study 33950795 — intervention group
Group type: COMPARATOR
Intervention: Video guide to echocardiographic anatomy alongside 3D printed models (3DM)
Number of subjects: 31
Study 33950795 — intervention group
Group type: COMPARATOR
Intervention: Video only (VO)
Number of subjects: 31
Study 34157970 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral Pecto-intercostal Fascial Block (PIFB)
Number of subjects: 108
Study 34157970 — intervention group
Group type: COMPARATOR
Intervention: No nerve block (SALI group)
Number of subjects: 108
Study 33396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake measured through 24 hDR; energy intake for 24–47 months: 4906.2 kJ (girls), 4997.9 kJ (boys); for 48–60 months: 5936.4 kJ (girls), 5621.2 kJ (boys); p = 0.038
Number of subjects: 116
Study 33396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Food frequency questionnaire used to calculate food variety and food group diversity scores; low fruit and vegetable consumption: 24–47 months; 63.8 g (girls), 69.5 g (boys); 48–60 months; 68.3 g (girls), 74.4 g (boys); p = 0.037 (24–47 months), p = 0.038 (48–60 months)
Number of subjects: 116
Study 33396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric measurements and WHO indicators; stunting noted in 7% (24–47 months) and 20% (48–60 months); p = 0.012
Number of subjects: 116
Study 33396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthropometric measurements; overweight in 8% (24–47 months) and 17% (48–60 months) for girls, 17% (24–47 months) and 13% (48–60 months) for boys; p = 0.041
Number of subjects: 116
Study 33396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood samples collected to determine serum retinol levels; low serum retinol (<0.070 μmol/L) found in 9.1% of boys (24–47 months), 8% (girls), and 7.4% (boys) (48–60 months)
Number of subjects: 116
Study 33396403 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood samples collected to determine haemoglobin levels; low haemoglobin (<11.0 g/dL) found in 50.0% (girls) and 30.4% (boys) (24–47 months), 8.6% (girls) and 39.3% (boys) (48–60 months)
Number of subjects: 116
Study 35379911 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced cleaning and disinfecting protocol
Number of subjects: 15814
Study 35379911 — intervention group
Group type: COMPARATOR
Intervention: Control schools cleaning as usual
Number of subjects: 15814
Study 33334634 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention (DTEXT)
Number of subjects: 395
Study 32181677 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 60,000 IU between 24 and 48 hours postpartum and at 6, 10, and 14 weeks (total 240,000 IU)
Number of subjects: 132
Study 32181677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132
Study 32181677 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 60,000 IU
Number of subjects: 132
Study 35235720 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole (2-4 mg/d for short-term studies; 1-4 mg/d for long-term studies)
Number of subjects: 831
Study 35235720 — intervention group
Group type: EXPERIMENTAL
Intervention: Brexpiprazole (1-4 mg/d)
Number of subjects: 831
Study 35235720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 831
Study 33883422 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic sphincter augmentation (MSA)
Number of subjects: 0
Study 33883422 — intervention group
Group type: COMPARATOR
Intervention: Fundoplication
Number of subjects: 0
Study 33318150 — intervention group
Group type: EXPERIMENTAL
Intervention: IV metoprolol (2×5 mg bolus)
Number of subjects: 683
Study 33318150 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 683
Study 33318150 — intervention group
Group type: EXPERIMENTAL
Intervention: IV metoprolol
Number of subjects: 683
Study 34983242 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Line screening (LLS) program
Number of subjects: 588198
Study 34983242 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 588198
Study 33157233 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice flour containing heat‐killed Lactobacillus paracasei CBA L74
Number of subjects: 100
Study 33157233 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35080260 — intervention group
Group type: COMPARATOR
Intervention: BRAF V600K mutation
Number of subjects: 142
Study 35080260 — intervention group
Group type: EXPERIMENTAL
Intervention: BRAF V600E mutation
Number of subjects: 142
Study 33475935 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration and Exercise Therapy (WBV + E)
Number of subjects: 24
Study 33475935 — intervention group
Group type: COMPARATOR
Intervention: Only Exercise Program (OE)
Number of subjects: 24
Study 33090213 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual counseling intervention
Number of subjects: 126
Study 33090213 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 126
Study 35025155 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenderness point group
Number of subjects: 105
Study 35025155 — intervention group
Group type: COMPARATOR
Intervention: Intervertebral foramen point group
Number of subjects: 105
Study 35025155 — intervention group
Group type: EXPERIMENTAL
Intervention: Articular process node group
Number of subjects: 105
Study 35025155 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison
Number of subjects: 105
Study 34031878 — intervention group
Group type: EXPERIMENTAL
Intervention: Seminar-based training
Number of subjects: 18
Study 34031878 — intervention group
Group type: COMPARATOR
Intervention: Control group (no seminar)
Number of subjects: 18
Study 35904770 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgical approach (group B)
Number of subjects: 60
Study 35904770 — intervention group
Group type: COMPARATOR
Intervention: Conventional approach (group A)
Number of subjects: 60
Study 34495376 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban (5 mg twice daily)
Number of subjects: 179
Study 34495376 — intervention group
Group type: COMPARATOR
Intervention: Aspirin (100 mg every day)
Number of subjects: 179
Study 32233666 — intervention group
Group type: EXPERIMENTAL
Intervention: Ross strain males and females
Number of subjects: 200
Study 32233666 — intervention group
Group type: COMPARATOR
Intervention: Cobb strain males and females
Number of subjects: 200
Study 32233666 — intervention group
Group type: EXPERIMENTAL
Intervention: Feather loss measurement
Number of subjects: 200
Study 32233666 — intervention group
Group type: EXPERIMENTAL
Intervention: Feather weight measurement
Number of subjects: 200
Study 32233666 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic equations for cumulative losses
Number of subjects: 200
Study 34893531 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP+HT
Number of subjects: 50
Study 34893531 — intervention group
Group type: COMPARATOR
Intervention: DPP only
Number of subjects: 50
Study 32187098 — intervention group
Group type: EXPERIMENTAL
Intervention: Females in trajectory Group 3 for Mode 1 in the femur
Number of subjects: 473
Study 32187098 — intervention group
Group type: EXPERIMENTAL
Intervention: Females in trajectory Group 2 for Mode 1 in the femur
Number of subjects: 473
Study 32187098 — intervention group
Group type: EXPERIMENTAL
Intervention: Females in trajectory Group 2 for Mode 1 in the tibia
Number of subjects: 473
Study 32187098 — intervention group
Group type: COMPARATOR
Intervention: Knees with OA in trajectory Group 3 for Mode 1 in the femur
Number of subjects: 473
Study 32187098 — intervention group
Group type: COMPARATOR
Intervention: Knees with OA in trajectory Group 2 for Mode 1 in the femur
Number of subjects: 473
Study 32187098 — intervention group
Group type: COMPARATOR
Intervention: Knees with OA in Mode 1 in the tibia
Number of subjects: 473
Study 34849694 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered toothbrush
Number of subjects: 52
Study 34849694 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 52
Study 34849694 — intervention group
Group type: EXPERIMENTAL
Intervention: Both manual and powered toothbrushes
Number of subjects: 52
Study 36157208 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy plus laparoscopic radical hysterectomy
Number of subjects: 42